Intranasal Diprospan Injection for Chronic Rhinosinusitis Treatment-Two Case Reports

Abstract

Chronic rhinosinusitis with nasal polyposis (CRSwNP) affects 0.5-4% of the world population and is present in ∼20% of patients with CRS. There are no definitive guidelines for the treatment of CRS largely due to the lack of consensus on the etiology of the disease. The management of chronic rhinosinusitis with nasal polyps, aimed at improving clinical symptoms, includes both surgical and medical treatments, but there is no universally accepted management protocol. Two case reports of CRSw NP treatment by intranasal Diprospan injection are presents. In both cases significant clinical and radiological improvement was observed without any side effects.